Institut für Mikrotechnik, Technische Universität Braunschweig, Alte Salzdahlumer Straße 203, 38124 Braunschweig, Germany; Center of Pharmaceutical Engineering - PVZ, Technische Universität Braunschweig, Franz-Liszt-Straße 35 A, 38106 Braunschweig, Germany.
Institut für Pharmazeutische Technologie, Technische Universität Braunschweig, Mendelssohnstraße 1, 38106 Braunschweig, Germany; Center of Pharmaceutical Engineering - PVZ, Technische Universität Braunschweig, Franz-Liszt-Straße 35 A, 38106 Braunschweig, Germany.
Eur J Pharm Biopharm. 2018 May;126:159-165. doi: 10.1016/j.ejpb.2017.04.022. Epub 2017 Apr 22.
Conventional safety and efficacy test models, such as animal experiments or static in vitro cell culture models, can often not reliably predict the most promising drug candidates. Therefore, a novel microfluidic cell culture platform, called Dynamic Micro Tissue Engineering System (DynaMiTES), was designed to allow online analysis of drugs permeating through barrier forming tissues under dynamic conditions combined with monitoring of the transepithelial electrical resistance (TEER) by electrodes optimized for homogeneous current distribution. A variety of pre-cultivated cell culture inserts can be integrated and exposed to well controlled dynamic micro flow conditions, resulting in a tightly regulated exposure of the cells to tested drugs, drug formulations and shear forces. With these qualities, the new system can provide more relevant information compared to static measurements. As a first in vitro model, a three-dimensional hemicornea construct consisting of human keratocytes (HCK-Ca) and epithelial cells (HCE-T) was successfully tested in the DynaMiTES. Thereby, we were able to demonstrate the functionality and cell compatibility of this new organ on chip test platform. The modular design of the DynaMiTES allows fast adaptation suitable for the investigation of drug permeation through other important cellular barriers.
传统的安全性和功效测试模型,如动物实验或静态体外细胞培养模型,往往不能可靠地预测最有前途的药物候选物。因此,设计了一种新型的微流控细胞培养平台,称为动态微组织工程系统 (DynaMiTES),允许在动态条件下在线分析透过形成屏障的组织的药物,同时通过针对均匀电流分布进行优化的电极监测跨上皮电阻 (TEER)。各种预培养的细胞培养插入物可以集成并暴露于控制良好的动态微流动条件下,从而使细胞受到测试药物、药物制剂和剪切力的严格调节暴露。通过这些特性,新系统可以提供比静态测量更相关的信息。作为第一个体外模型,成功地在 DynaMiTES 中测试了由人角膜细胞 (HCK-Ca) 和上皮细胞 (HCE-T) 组成的三维半角膜构建体。由此,我们能够证明这种新型器官芯片测试平台的功能和细胞相容性。DynaMiTES 的模块化设计允许快速适应适合研究其他重要细胞屏障的药物渗透。